Accredo

Last updated
Accredo Health Group, Inc.
Company type Subsidiary
Industry Health care
PredecessorSouthern Health Systems
Founded1996;28 years ago (1996)
Headquarters
Memphis, Tennessee
,
U.S.
Parent Express Scripts
Website www.accredo.com

Accredo Health Group, Inc. is a specialty pharmaceutical and service provider for patients with complex and chronic health conditions. [1] Accredo provides specialty drugs, drugs that cost more than $600 per month, with the average being $10,000 a month, which treat serious conditions such as multiple sclerosis, rheumatoid arthritis, hemophilia and cancer. [1] It is a wholly owned subsidiary of Express Scripts and is headquartered in Memphis, Tennessee. [2] [3]

Contents

History

In 1980s Memphis, Tennessee, the Le Bonheur Children's Medical Center formed two companies to distribute drugs to the American Southeast, Nova Factor and Southern Health Systems (SHS). SHS specialized in hormone and clotting drugs for children. [1] Accredo Health, Inc. was incorporated in 1996 to acquire both businesses. Soon thereafter, it acquired Hemophilia Health Services (HHS). In 1999, Accredo filed its initial public offering and became a public company, trading on Nasdaq under the ticker "ACDO". [4] [5] In 2004, Medco Health Solutions allied with Accredo Health to form a specialty pharmacy. In June of that year, Accredo's wholly owned subsidiary HHS acquired Hemophilia Resources of America. [6] In August the following year, Medco acquired Accredo and it became a wholly owned subsidiary of the company. [3] In 2012, Express Scripts acquired Medco, making Accredo a wholly owned subsidiary of Express Scripts. [7] [8] As a result, Accredo merged with CuraScript SP Specialty Pharmacy, operating under its current name. [1]

Services

Accredo offers "Therapeutic Resource Centers" (TRCs) for specialty conditions, such as asthma, cystic fibrosis, HIV, multiple sclerosis and rheumatoid arthritis. [9] In partnership with Eviti, Inc., an oncology TRC includes decision support tools for physicians and patients. [10] It is broken up into subdivisions for types of cancer to provide drug-specific support. [1] The purpose of the teams is to provide specialty drugs, ensure dosage is correct for each patient, and encourage drug compliance to reduce waste and costs for all parties. [10] [11] [12] Side effect management is an important part of TRCs, as they are a large contributor to patients not complying with their drug regimens. Pharmacists and nurses also provide patient counseling and education. [12]

The company's Clinical Day Supply program addresses patient noncompliance with oral oncology drug regimens. To reduce waste as well as to monitor patient drug tolerance, Accredo gave only a half fill of prescription medications, then performed a clinical assessment to monitor patient drug tolerance and help ensure that patients do not take unnecessary or ineffective drugs. With the program, treatment options can also be reexamined if the drugs are working, but side effects are hindering quality of life. [11]

Criticism

Accredo is not accredited by the Better Business Bureau, [13] and has received class action lawsuits over Accredi's poor patient ethics and failure to provide basic services. [14] [15] [16] A 2019 investigation by Olga Khazan in The Atlantic documented how Accredo and other specialty pharmacies harm patients in their efforts to cut costs as they delay sending medications for weeks and, at times, months. [17]

Related Research Articles

<span class="mw-page-title-main">Pharmacy</span> Clinical health science

Pharmacy is the science and practice of discovering, producing, preparing, dispensing, reviewing and monitoring medications, aiming to ensure the safe, effective, and affordable use of medicines. It is a miscellaneous science as it links health sciences with pharmaceutical sciences and natural sciences. The professional practice is becoming more clinically oriented as most of the drugs are now manufactured by pharmaceutical industries. Based on the setting, pharmacy practice is either classified as community or institutional pharmacy. Providing direct patient care in the community of institutional pharmacies is considered clinical pharmacy.

Prescription drug list prices in the United States continually are among the highest in the world. The high cost of prescription drugs became a major topic of discussion in the 21st century, leading up to the American health care reform debate of 2009, and received renewed attention in 2015. One major reason for high prescription drug prices in the United States relative to other countries is the inability of government-granted monopolies in the American health care sector to use their bargaining power to negotiate lower prices, and the American payer ends up subsidizing the world's R&D spending on drugs.

McKesson Corporation is a publicly-traded American company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 51,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a member of the S&P 500 and New York Stock Exchange, where it is traded under the ticker symbol NYSE: MCK.

Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001.

Medco Health Solutions, Inc. was an American Pharmacy Benefits Management (PBM) company. Medco provided pharmacy services to private and public employers, health plans, labor unions, government agencies, and individuals served by Medicare Part D Prescription Drug Plans.

Express Scripts Holding Company is a pharmacy benefit management (PBM) organization. In 2017 it was the 22nd-largest company in the United States by total revenue as well as the largest pharmacy benefit management (PBM) organization in the United States. Express Scripts had 2016 revenues of $100.752 billion. Since December 20, 2018, the company has been a direct subsidiary of Bloomfield, Connecticut-based Cigna.

IMS Health was an American company that provided information, services and technology for the healthcare industry. IMS stood for Intercontinental Medical Statistics. It was the largest vendor of U.S. physician prescribing data. IMS Health was founded in 1954 by Bill Frohlich and David Dubow with Arthur Sackler having a hidden ownership stake. In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green & Partners. The company went public on April 4, 2014, and began trading on the NYSE under the symbol IMS. IMS Health was headquartered in Danbury, Connecticut.

In the United States, a pharmacy benefit manager (PBM) is a third-party administrator of prescription drug programs for commercial health plans, self-insured employer plans, Medicare Part D plans, the Federal Employees Health Benefits Program, and state government employee plans. According to the American Pharmacists Association, "PBMs are primarily responsible for developing and maintaining the formulary, contracting with pharmacies, negotiating discounts and rebates with drug manufacturers, and processing and paying prescription drug claims." PBMs operate inside of integrated healthcare systems, as part of retail pharmacies, and as part of insurance companies.

CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the Forbes Global 2000.

<span class="mw-page-title-main">Sumitomo Pharma</span> Pharmaceutical company based in Japan

Sumitomo Pharma Company Limited is a Japanese multinational pharmaceutical company. The company is focused on oncology, psychiatry, neurology, women's health issues, urological diseases among other areas. Its headquarters are located in Chuo-ku, Osaka.

Inovalon is an American technology company that provides cloud-based tools for healthcare.

<span class="mw-page-title-main">Merck & Co.</span> American multinational pharmaceutical company

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of which it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. It is one of the largest pharmaceutical companies in the world, generally ranking in the global top five by revenue.

<span class="mw-page-title-main">Avella Specialty Pharmacy</span> Pharmaceutical specialty company

Avella Specialty Pharmacy, formerly known as The Apothecary Shops, is an American specialty pharmacy company. Avella is headquartered in Phoenix, Arizona, and has facilities in eight states. Dr. John D. Musil is the company's founder. Rebecca Shanahan is the CEO.

Specialty drugs or specialty pharmaceuticals are a recent designation of pharmaceuticals classified as high-cost, high complexity and/or high touch. Specialty drugs are often biologics—"drugs derived from living cells" that are injectable or infused. They are used to treat complex or rare chronic conditions such as cancer, rheumatoid arthritis, hemophilia, H.I.V. psoriasis, inflammatory bowel disease and hepatitis C. In 1990 there were 10 specialty drugs on the market, around five years later nearly 30, by 2008 200, and by 2015 300.

Philidor Rx Services is a Pennsylvania-licensed specialty online pharmacy, which mainly sold Valeant Pharmaceuticals International Inc drugs directly to patients and handled insurance claims on the customers' behalf.

Specialty pharmacy refers to distribution channels designed to handle specialty drugs — pharmaceutical therapies that are either high cost, high complexity and/or high touch. High touch refers to higher degree of complexity in terms of distribution, administration, or patient management which drives up the cost of the drugs. In the early years specialty pharmacy providers attached "high-touch services to their overall price tags" arguing that patients who receive specialty pharmaceuticals "need high levels of ancillary and follow-up care to ensure that the drug spend is not wasted on them." An example of a specialty drug that would only be available through specialty pharmacy is interferon beta-1a (Avonex), a treatment for MS that requires a refrigerated chain of distribution and costs $17,000 a year. Some specialty pharmacies deal in pharmaceuticals that treat complex or rare chronic conditions such as cancer, rheumatoid arthritis, hemophilia, H.I.V. psoriasis, inflammatory bowel disease (IBD) or Hepatitis C. "Specialty pharmacies are seen as a reliable distribution channel for expensive drugs, offering patients convenience and lower costs while maximizing insurance reimbursements from those companies that cover the drug. Patients typically pay the same co-payments whether or not their insurers cover the drug." As the market demanded specialization in drug distribution and clinical management of complex therapies, specialized pharma (SP) evolved.„ Specialty pharmacies may handle therapies that are biologics, and are injectable or infused. By 2008 the pharmacy benefit management dominated the specialty pharmacies market having acquired smaller specialty pharmacies. PBMs administer specialty pharmacies in their network and can "negotiate better prices and frequently offer a complete menu of specialty pharmaceuticals and related services to serve as an attractive 'one-stop shop' for health plans and employers."

Diplomat Pharmacy, Inc. is the largest independent provider of specialty pharmacy services in the United States. The company partners with manufacturers, payers, providers, hospitals, and more. Headquartered in Flint, Michigan, Diplomat has facilities across the United States and dispenses drugs in all 50 states. Diplomat offers specialized medication and medication management programs for patients with complex and chronic conditions such as cancer, hepatitis, multiple sclerosis, HIV and others.

Timothy C. Wentworth is an American businessman and CEO of pharmacy operator Walgreens Boots Alliance. He is a former CEO of Evernorth, Cigna's health services platform and a former CEO of Express Scripts, the United States' largest pharmacy benefit manager.

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

RXNT is an American privately held healthcare software technology company. The company provides ambulatory practices, hospitals, medical billers, and other healthcare professionals with digital health tools. The company was created in 1999, as a standalone e-prescribing system.

References

  1. 1 2 3 4 5 Sells, Toby (January 31, 2013). "Signs point to Accredo surviving the Express Scripts takeover of Medco". The Commercial Appeal . Archived from the original on August 13, 2014. Retrieved December 3, 2014.
  2. ↑ Lytle, Tamara (March 1, 2014). "Soaring Specialty Drug Costs Require HR Response". Society for Human Resource Management . Vol. 59, no. 3. Archived from the original on April 23, 2014. Retrieved December 3, 2014.
  3. 1 2 Hollahan, Terry (March 28, 2014). "Some Investments Have a Shelf Life". Memphis Business Journal. American City Business Journals. Archived from the original on August 6, 2016. Retrieved December 3, 2014.
  4. ↑ "Accredo Health Announces IPO". Memphis Business Journal. American City Business Journals. April 16, 1999. Archived from the original on November 23, 2002. Retrieved December 3, 2014.
  5. ↑ "Accredo Health Inc (ACDO)". Nasdaq . Retrieved December 3, 2014.
  6. ↑ "Accredo to buy HRA Holding". Memphis Business Journal. American City Business Journals. July 4, 2004. Retrieved April 17, 2024.
  7. ↑ Reed Abelson; Natasha Singer (April 2, 2012). "F.T.C. Approves Merger of 2 of the Biggest Pharmacy Benefit Managers". The New York Times. Retrieved December 3, 2014.
  8. ↑ Nunnery, Nash (May 10, 2012). "10 Best Places to Work: Gilberts Home Health". Mississippi Business Journal .
  9. ↑ "Patient Care". Accredo. Archived from the original on April 17, 2024. Retrieved April 17, 2024.
  10. 1 2 Davis, Warren (2014). "Waste and Missed Opportunities Drive Costs Upward". Clinical Advances in Hematology & Oncology. 12 (1). Millennium Medical Publishing: 65.
  11. 1 2 Mohanty, Monalisa; Cast, Kevin (August 8, 2013). "Cancer Patients Require Coordinated Care". Pharmacy Times. Vol. 4, no. 4. Archived from the original on February 8, 2023. Retrieved December 3, 2014.
  12. 1 2 Benesh, Peter (April 12, 2010). "If it's the Only Cure, It's Going to Cost You: Specialty Drugs Grow Rise in Health Care Costs Spurred by Treatment for Scare Conditions". Investor's Business Daily .
  13. ↑ "Accredo Health Group, Inc". Better Business Bureau . Retrieved December 13, 2023.
  14. ↑ "Manhattan U.S. Attorney Announces $60 Million Civil Fraud Settlement With Accredo Health Group Over Kickback Scheme Involving Prescription Drug". Office of Inspector General, U.S. Department of Health and Human Services . May 1, 2015. Archived from the original on April 13, 2021. Retrieved April 17, 2024.
  15. ↑ "In re Accredo Health, Inc. Securities Litigation". Bernstein Litowitz Berger & Grossmann . Archived from the original on August 4, 2021. Retrieved April 17, 2024.
  16. ↑ "A.G. Schneiderman Announces $375,000 Settlement With Specialty Pharmacy Over Failure To Provide Basic Services". Attorney General of New York (Press release). March 22, 2018. Archived from the original on August 6, 2020. Retrieved April 17, 2024.
  17. ↑ Khazan, Olga (April 9, 2019). "Invisible Middlemen Are Slowing Down American Health Care". The Atlantic . Archived from the original on July 15, 2023. Retrieved December 13, 2023.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.